a lonely feeling
is all around this webpage
can't find one like it
If you are certain you have the correct web address but are encountering an error, please contact the Site Administration. Thank you.
You are seeing this haiku because the page you were looking for cannot be found.
We apologize for the inconvenience, but the page you were trying to access is not at this address. You can use the links below to help you find what you are looking for.
You might have been looking for…
- HPS3 / TIMI 55 - REVEAL : Randomised Evaluation of the Effects of Anacetrapib through Lipid-modification
- HPS3 / TIMI 55 - REVEAL : Randomised Evaluation of the Effects of Anacetrapib through Lipid-modification
-
Michael Lay
Michael Lay - Head of Project Information Science
-
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
AIMS: REVEAL was the first randomized controlled trial to demonstrate that adding cholesteryl ester transfer protein inhibitor therapy to intensive statin ...
-
Impact of ADCY9 Genotype on Response to Anacetrapib.
BACKGROUND: Exploratory analyses of previous randomized trials generated a hypothesis that the clinical response to CETP inhibitor therapy differs by ADCY9 ...
-
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of ...